fbpx
gray bg blue bg

New study for patients who have both fatty liver disease & Type 2 Diabetes.

Please fill in your details

Please enter first name.
Please enter last name.
Please enter valid email.
Please enter valid contact number.
Please select type of diabetes.
Kindly fill in above all mandatory fields

About the Study


This study is for participants who have fatty liver disease and Type 2 Diabetes. The study is looking at a once daily oral medication to reduce fat in the liver. 

Fatty liver is the most common cause of chronic liver disease in North America. There is currently no approved medication to help fatty liver.

Please fill in your details

Please enter first name.
Please enter last name.
Please enter valid email.
Please enter valid contact number.
Please select type of diabetes.
Kindly fill in above all mandatory fields